周五早盘，医渡科技（02158.HK）股价表现强劲，盘中大涨5.09%，引发市场关注。这一股价上涨或与公司最新公布的财务管理举措有关。
据公司公告，医渡科技于6月5日认购了两笔大额财资管理产品。具体而言，公司分别向高盛（Goldman Sachs）和摩根大通（JPMorgan Chase Bank）各认购了6000万美元的可赎回固定票息票据，总额达1.2亿美元。这些产品的期限最长为5年，预期年收益率分别介于4.3%-6.1%和4.25%-5%之间。
分析人士认为，医渡科技此举表明公司拥有充裕的现金流，并积极进行资金管理。这一大手笔投资可能增强了投资者对公司财务状况和经营能力的信心，从而推动股价上涨。然而，投资者仍需关注公司未来的经营表现和行业发展趋势，以评估长期投资价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.